BNET Industries
Market Cap:$289.0M
Last Fiscal Year Sales:$91.8M
- Public
Dow Jones Description
Comet Technologies, Inc. (the "Company" or "Comet") is a "blank check" company which has been seeking to locate a business enterprise which it may acquire, merge or reorganize with, or become engaged in. The Company has been inactive for several years, and until January, 2004, when it entered into an agreement with Town House Land Limited, discussed below, had not located any specific business enterprise for its involvement, nor had it entered into any arrangement or agreements with respect thereto. Since the completion of the Company's public offering in August 1986, the Company has reviewed and evaluated numerous business ventures for possible acquisition or participation by the Company. To date, the Company has not acquired any business venture or engaged in any active operations. The Company was inactive until January, 2004, when the Company entered into a Stock Exchange Agreement (the "Exchange Agreement") with Town House Land Limited ("Town House"), a company organized in the Hong Kong Special Administrative Region in The People's Republic of China, and the shareholders of Town House, providing for the acquisition of Town House in a reverse acquisition.
Chief Financial Officer
Han XiaoNumber of Employees 1,804
Contact Information
No. 38 Dingxin 3rd Street
Nangang District, Heilongjiang Province
Harbin 150001
213-488-5131
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
China Sky One Nears Approval on Two Diagnostic Tests
-
Gentium loses CEO, board
News & Analysis
Filter by
china sky one medical inc. and manuel asensio - All News and Analysis
China Sky's Financial Statements: Huge Discrepancies
Seeking Alpha
- 2009-11-24
On August 6th, we first reported on discrepancies between the financial statements of China Sky One Medical, Inc. CSKI filed with U.S. and Chinese regulatory agencies. CSKI files consolidated financial statements with the U.S. Securities and Exchange Commission (SEC), and CSKI's operating subsidiaries, all located in China, file financial...
China Sky's Financial Irregularities Continue in Third Quarter Earnings
Seeking Alpha
- 2009-11-24
China Sky One Medical, Inc. CSKI released its third-quarter earnings on November 17, 2009. The financial irregularities that asensio.com began reporting on in April 2009 continued to be evident in CSKI’s third-quarter financial statements. China Sky continues to report a questionably low inventory level. asensio.com compared CSKI to...
China Sky's Weight-Loss Patch Has a Questionable Future
Seeking Alpha
- 2009-06-17
China Sky One Medical, Inc. CSKI states in its 10-K that its weight-loss patch product, the Sumei Slim Patch, is "believed to foster weight loss and prevent weight gain." The Sumei Slim Patch comprised 22% of China Sky's total sales in 2008, according to the company's fourth quarter earnings...
China Sky, Takasima and Massage Chairs: A Tangled Web
Seeking Alpha
- 2009-05-31
China Sky One Medical, Inc. (NASDAQ: CSKI) reported in its 2006 10-K that in March 2007 it entered into an agreement with a Malaysian company called Takasima Industries for the distribution in Malaysia of China Sky's Slim Patch product. Under the terms of the agreement, Takasima was required to generate...
China Sky Confusion: Management Is Flying in Circles
Seeking Alpha
- 2009-05-20
Yesterday, China Sky One Medical, Inc. CSKI issued a press release stating that it had engaged Pricewaterhouse Coopers to assist the company in complying with the financial reporting and control requirements of the Sarbanes-Oxley Act. Pricewaterhouse will not become the company's auditor. China Sky is only engaging the firm as...
China Sky's Reported First Quarter Earnings Raise More Questions
Seeking Alpha
- 2009-05-15
China Sky One Medical, Inc. CSKI released first quarter earnings on May 14. The disclosures made in China Sky's earnings announcement and Form 10-Q for the first quarter continue to underscore the issues raised previously by asensio.com, concerning margins and inventory levels. China Sky's disclosures also raise new questions. China...
China Sky's Reported Inventory Belies Its Stated Earnings and Sales
Seeking Alpha
- 2009-05-08
An analysis of China Sky One Medical, Inc.'s CSKI inventory reporting, as well as certain customer and supplier disclosures, raises serious questions about the accuracy of its reported sales and earnings. Reports previously issued by asensio.com revealed discrepancies in China Sky's stated EPS, gross margins and average sales prices, along...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Han Xiao | Chief Financial Officer |
| Han Xiao-Yan | Principal Financial Officer and Director |
| Wen Chao Zhang | Director of Scientific and Technological Development |
Ms. Han had five years of hygiene and medical media experience before joining TDR. She has been instrumental in developing and marketing TDR’s products and expanding its sales. She serves as a senior marketing manager and administrative manager and has 10 years of financial management experience. In 2004, she was appointed the general manager of TDR, with responsibility for financing, production, quality control and purchasing. In 2003, she was appointed director of Harbin First Bio-Engineering. She received Master of Business Administration at Harbin Industrial University in 2004. Ms. Han Xiao-yan owns 1,406,717 shares, 8.9% of outstanding shares.
| Organization | Position | Status |
|---|---|---|
| China Sky One Medical, Inc. | Chief Financial Officer | Current |
| Organization | Position | Status |
|---|---|---|
| China Sky One Medical, Inc. | Principal Financial Officer and Director | Current |
| Organization | Position | Status |
|---|---|---|
| China Sky One Medical, Inc. | Director of Scientific and Technological Development | Current |
| Volume | 170,056 |
| Shares Outstanding | 16.6M |
| Market Cap | 289.0M |
| Year High | 19.11 |
| Year Low | 10.030 |
| Earnings Per Share | 2.19 |
| P/E Ratio | 7.9224 |
| Dividend | 0.00 |
| Yield | 0.00 |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
